These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 12521697

  • 1. First-trimester pregnancy scanning as a screening tool for high-risk and abnormal pregnancies in a district general hospital setting.
    Drysdale K, Ridley D, Walker K, Higgins B, Dean T.
    J Obstet Gynaecol; 2002 Mar; 22(2):159-65. PubMed ID: 12521697
    [Abstract] [Full Text] [Related]

  • 2. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K, Nicolaides KH.
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [Abstract] [Full Text] [Related]

  • 3. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V, Markov D, Chernev T, Karag'ozova Zh, Mazneĭkova V, Andonova S, Vŭzharova R.
    Akush Ginekol (Sofiia); 2005 Mar; 44(1):32-7. PubMed ID: 15853009
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA, Bakker M, Bardi F, Fontanella F, Bakker MK, Fleurke-Rozema JH, Bilardo CM.
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation.
    Syngelaki A, Hammami A, Bower S, Zidere V, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):468-476. PubMed ID: 31408229
    [Abstract] [Full Text] [Related]

  • 6. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJ, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
    [Abstract] [Full Text] [Related]

  • 7. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D, Chernev T, Dimitrova V, Mazneĭkova V, Leroy Y, Jacquemyn Y, Ramaekers P, Van Bulck B, Loquet P.
    Akush Ginekol (Sofiia); 2004 Jan; 43(3):3-10. PubMed ID: 15341249
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low-risk and unselected populations.
    Buijtendijk MF, Bet BB, Leeflang MM, Shah H, Reuvekamp T, Goring T, Docter D, Timmerman MG, Dawood Y, Lugthart MA, Berends B, Limpens J, Pajkrt E, van den Hoff MJ, de Bakker BS.
    Cochrane Database Syst Rev; 2024 May 09; 5(5):CD014715. PubMed ID: 38721874
    [Abstract] [Full Text] [Related]

  • 9. Screening for structural fetal anomalies during the nuchal translucency ultrasound examination.
    Weiner Z, Goldstein I, Bombard A, Applewhite L, Itzkovits-Eldor J.
    Am J Obstet Gynecol; 2007 Aug 09; 197(2):181.e1-5. PubMed ID: 17689643
    [Abstract] [Full Text] [Related]

  • 10. Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis.
    Borruto F, Comparetto C, Acanfora L, Bertini G, Rubaltelli FF.
    Clin Exp Obstet Gynecol; 2002 Aug 09; 29(4):235-41. PubMed ID: 12635737
    [Abstract] [Full Text] [Related]

  • 11. Screening for major structural abnormalities at the 11- to 14-week ultrasound scan.
    Souka AP, Pilalis A, Kavalakis I, Antsaklis P, Papantoniou N, Mesogitis S, Antsaklis A.
    Am J Obstet Gynecol; 2006 Feb 09; 194(2):393-6. PubMed ID: 16458635
    [Abstract] [Full Text] [Related]

  • 12. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
    Drummond CL, Gomes DM, Senat MV, Audibert F, Dorion A, Ville Y.
    Prenat Diagn; 2003 Dec 30; 23(13):1068-72. PubMed ID: 14691994
    [Abstract] [Full Text] [Related]

  • 13. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.
    Saltvedt S, Almström H, Kublickas M, Valentin L, Bottinga R, Bui TH, Cederholm M, Conner P, Dannberg B, Malcus P, Marsk A, Grunewald C.
    Ultrasound Obstet Gynecol; 2005 Jun 30; 25(6):537-45. PubMed ID: 15912479
    [Abstract] [Full Text] [Related]

  • 14. Optimising the timing for nuchal translucency measurement.
    Mulvey S, Baker L, Edwards A, Oldham J, Shekleton P, Wallace EM.
    Prenat Diagn; 2002 Sep 30; 22(9):775-7. PubMed ID: 12224069
    [Abstract] [Full Text] [Related]

  • 15. Fetal structural anomaly screening at 11-14 weeks of gestation at Maharaj Nakorn Chiang Mai Hospital.
    Srisupundit K, Tongsong T, Sirichotiyakul S, Chanprapaph P.
    J Med Assoc Thai; 2006 May 30; 89(5):588-93. PubMed ID: 16756041
    [Abstract] [Full Text] [Related]

  • 16. [First trimester ultrasound screening for structural and chromosomal anomalies in multiple pregnancy].
    Markov D, Chernev T, Dimitrova V, Masneĭkova V, Leroy Y, Jacquemyn Y, Ramaekers P, Van Bulck B, Loquet P.
    Akush Ginekol (Sofiia); 2004 May 30; 43(5):11-8. PubMed ID: 15518278
    [Abstract] [Full Text] [Related]

  • 17. Two-stage ultrasonography in screening for fetal anomalies at 13-14 and 18-22 weeks of gestation.
    Taipale P, Ammälä M, Salonen R, Hiilesmaa V.
    Acta Obstet Gynecol Scand; 2004 Dec 30; 83(12):1141-6. PubMed ID: 15548146
    [Abstract] [Full Text] [Related]

  • 18. Does fetal screening affect women's worries about the health of their baby? A randomized controlled trial of ultrasound screening for Down's syndrome versus routine ultrasound screening.
    Georgsson Ohman S, Saltvedt S, Grunewald C, Waldenström U.
    Acta Obstet Gynecol Scand; 2004 Jul 30; 83(7):634-40. PubMed ID: 15225187
    [Abstract] [Full Text] [Related]

  • 19. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
    Schuchter K, Hafner E, Stangl G, Ogris E, Philipp K.
    Ultrasound Obstet Gynecol; 2001 Jul 30; 18(1):23-5. PubMed ID: 11489220
    [Abstract] [Full Text] [Related]

  • 20. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
    Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH.
    BJOG; 2003 Mar 30; 110(3):281-6. PubMed ID: 12628268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.